Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name BC032020
   Synonyms ZNF451-AS1
   Region GRCh38_6:57114894-57174236    Sequence
   Ensembl ENSG00000226803
   RefSeq NR_110742
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name pancreatic ductal adenocarcinoma
   ICD-0-3 C25.3  M8500/3
   Methods qPCR, Western blot,in vitro knockdown etc.
   Sample cell lines (AsPC-1(CRL-1682), BxPC-3 (CRL-1687), PANC-1 (CRL-1469),CFPAC-1 (CRL-1918), MIA PaCa-2 (CRL-1420)), pancreatic cancer tissues
   Expression Pattern down-regulated
   Function Description

BC032020 levels in the PDAC tumor tissues were lower than those in the adjacent normal tissues, and ZNF451 expression inversely correlated with the BC032020 levels in the PDAC tumor tissues and cell lines. BC032020 overexpression led to a decrease in ZNF451 expression; it also suppressed the proliferation and migration of the AsPC-1 and PANC-1 cells, and induced G1 phase arrest and cell apoptosis. The results of in vivo experiments revealed that BC032020 suppressed tumor growth in a xenograft model by inhibiting ZNF451 expression. Taken together, the findings of this study indicate that BC032020 suppresses the survival of PDAC cells by inhibiting ZNF451 expression.

   Pubmed ID 29532883
   Year 2018
   Title LncRNA BC032020 suppresses the survival of human pancreatic ductal adenocarcinoma cells by targeting ZNF451.
   External Links
   Links for  BC032020 GenBank       HGNC       lncrnadb       Noncode
   Links for  pancreatic ductal adenocarcinoma Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.